Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Other Non-Current Assets (2021 - 2025)

Medicinova (MNOV) has disclosed Other Non-Current Assets for 7 consecutive years, with $18996.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $18996.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $18996.0, a N/A change, with the full-year FY2025 number at $18996.0, changed N/A from a year prior.
  • Other Non-Current Assets was $18996.0 for Q4 2025 at Medicinova, roughly flat from $18996.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.8 million in Q1 2021 to a low of $18996.0 in Q3 2024.
  • A 5-year average of $2.7 million and a median of $4.8 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 6719.05% in 2025; the steepest drop was 99.6% in 2025.
  • Medicinova's Other Non-Current Assets stood at $4.8 million in 2021, then changed by 0.0% to $4.8 million in 2022, then crashed by 98.46% to $74151.0 in 2023, then tumbled by 74.38% to $18996.0 in 2024, then changed by 0.0% to $18996.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Other Non-Current Assets are $18996.0 (Q4 2025), $18996.0 (Q3 2025), and $18996.0 (Q2 2025).